Chig Fung Cheng
Acting CEO, CFO & Executive DirectorMr. Chig Fung Cheng, BEc, CA, also known as Johnny, has been Chief Financial Officer of HUTCHMED (China) Limited (formerly known as Hutchison China MediTech Limited) since July 2008 and serves as its Acting CEO from August 25. 2025. Mr. Cheng serves as Executive of Hutchison Whampoa Ltd. He has worked in Chi-Med as Chief Financial Officer for over two years. Prior to joining Chi-Med, Mr. Cheng was the Vice President of Finance of Bristol Myers Squibb in China and was a Director of Sino-American Shanghai Squibb Pharmaceuticals Ltd. and Bristol-Myers Squibb (China) Investment Co. Ltd. in Shanghai between late 2006 and 2008. Mr. Cheng started his career as an auditor with Price Waterhouse in Australia and then KPMG in Beijing before spending eight years with Nestle China where he was in charge of a number of finance and control functions in various operations. He has been an Executive Director at HUTCHMED (China) Limited (formerly known as Hutchison China MediTech Limited) since 2011. He serves as a Director of Hutchison MediPharma (Hong Kong) Limited, Sen Medicine Company Limited, Hutchison MediPharma Limited, Hutchison MediPharma (Suzhou) Limited and Hutchison MediPharma (Yulin) Limited. He was a Director of Hutchison Healthcare Limited during 2009. Mr. Cheng received a Bachelor of Economics, Accounting Major from the University of Adelaide and is a member of the Institute of Chartered Accountants in Australia.
Positions
- Company NameHUTCHMED (China) LimitedStock Code00013PositionActing CEO, CFO & Executive DirectorRelated SecuritiesColleagues
- DEDan EldarNon-Executive Chairman
- WSWei-Guo SuCEO, Chief Scientific Officer & Executive Director (Leave of Absence)
- YCYiling CuiExecutive VP & Head of Operations
- XHXinhui HuExecutive Vice President & Chief Technical Officer
- EKEmily KwongVice President of Capital Markets & Investor Relations
- ESEdith ShihCompany Secretary & Non-Executive Director
- RBRenu BhatiaLead Independent Non-executive Director
